CMBL Antikörper (AA 2-245)
-
- Target Alle CMBL Antikörper anzeigen
- CMBL (Carboxymethylenebutenolidase Homolog (CMBL))
-
Bindungsspezifität
- AA 2-245
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser CMBL Antikörper ist unkonjugiert
- Applikation
- ELISA, Western Blotting (WB), Immunohistochemistry (IHC), Immunofluorescence (IF)
- Kreuzreaktivität
- Human, Maus
- Aufreinigung
- >95%, Protein G purified
- Immunogen
- Recombinant Human Carboxymethylenebutenolidase homolog protein (2-245AA)
- Isotyp
- IgG
-
-
- Applikationshinweise
- Recommended dilution: WB:1:500-1:2000, IHC:1:20-1:200, IF:1:50-1:200,
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 - Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- CMBL (Carboxymethylenebutenolidase Homolog (CMBL))
- Andere Bezeichnung
- CMBL (CMBL Produkte)
- Synonyme
- JS-1 antikoerper, RGD1306952 antikoerper, 2310016A09Rik antikoerper, carboxymethylenebutenolidase homolog antikoerper, carboxymethylenebutenolidase-like (Pseudomonas) antikoerper, CMBL antikoerper, Cmbl antikoerper
- Hintergrund
-
Background: Cysteine hydrolase. Can convert the prodrug olmesartan medoxomil into its pharmacologically active metabolite olmerstatan, an angiotensin receptor blocker, in liver and intestine. May also activate beta-lactam antibiotics faropenem medoxomil and lenampicillin.
Aliases: Carboxymethylenebutenolidase homolog (Pseudomonas) antibody, Carboxymethylenebutenolidase homolog antibody, cmbl antibody, CMBL_HUMAN antibody, FLJ23617 antibody
- UniProt
- Q96DG6
-